UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (836) 836
life sciences & biomedicine (817) 817
humans (775) 775
male (446) 446
female (423) 423
infectious diseases (402) 402
middle aged (365) 365
antifungal agents - therapeutic use (356) 356
aspergillosis (347) 347
mycoses (341) 341
adult (323) 323
invasive aspergillosis (303) 303
aged (266) 266
risk factors (256) 256
antifungal agents (219) 219
health aspects (219) 219
microbiology (207) 207
mycology (205) 205
retrospective studies (202) 202
mortality (188) 188
transplantation (181) 181
hematology (179) 179
invasive fungal infection (170) 170
adolescent (167) 167
immunocompromised host (160) 160
fungal infections (148) 148
young adult (148) 148
biological and medical sciences (144) 144
aspergillus (143) 143
epidemiology (143) 143
diagnosis (140) 140
medical sciences (136) 136
patients (128) 128
invasive pulmonary aspergillosis (124) 124
child (123) 123
immunology (119) 119
treatment outcome (117) 117
invasive fungal infections (116) 116
medicine & public health (116) 116
care and treatment (114) 114
dermatology (114) 114
invasive pulmonary aspergillosis - diagnosis (113) 113
incidence (110) 110
aspergillosis - drug therapy (105) 105
fungi (105) 105
invasive pulmonary aspergillosis - drug therapy (103) 103
oncology (103) 103
neutropenia (102) 102
antifungal agents - administration & dosage (99) 99
invasive pulmonary aspergillosis - epidemiology (99) 99
cancer (98) 98
voriconazole (98) 98
research (97) 97
internal medicine (93) 93
aged, 80 and over (89) 89
aspergillosis - diagnosis (89) 89
infections (87) 87
mycoses - drug therapy (87) 87
analysis (86) 86
invasive fungal disease (86) 86
aspergillus - isolation & purification (85) 85
leukemia (85) 85
prophylaxis (84) 84
chemotherapy (83) 83
hematopoietic stem cells (83) 83
stem cells (83) 83
aspergillosis - epidemiology (82) 82
hematologic neoplasms - complications (80) 80
invasive pulmonary aspergillosis - microbiology (79) 79
mycoses - epidemiology (77) 77
pharmacology & pharmacy (77) 77
candidiasis (76) 76
human mycoses (76) 76
pulmonary aspergillosis (76) 76
child, preschool (75) 75
aspergillosis - microbiology (74) 74
galactomannan (72) 72
amphotericin b (71) 71
general & internal medicine (71) 71
transplants & implants (71) 71
pediatrics (70) 70
hematopoietic stem cell transplantation - adverse effects (66) 66
medical research (64) 64
sensitivity and specificity (64) 64
triazoles - therapeutic use (64) 64
aspergillus fumigatus (63) 63
mucormycosis (63) 63
prospective studies (63) 63
infection (61) 61
antifungal agents - pharmacology (60) 60
hematopoietic stem cell transplantation (58) 58
animals (57) 57
mycoses - microbiology (57) 57
posaconazole (56) 56
prognosis (56) 56
review (56) 56
invasive fungal infections - drug therapy (55) 55
mannans - blood (54) 54
medicine (54) 54
medicine, experimental (53) 53
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1119) 1119
German (44) 44
French (12) 12
Portuguese (8) 8
Spanish (7) 7
Japanese (1) 1
Russian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical infectious diseases, ISSN 1058-4838, 5/2011, Volume 52, Issue 9, pp. 1123 - 1129
Polymerase chain reaction | Antifungals | Aspergillus | Azoles | Triazoles | Aspergillosis | Sputum | ARTICLES AND COMMENTARIES | Allergic bronchopulmonary aspergillosis | Aspergillus fumigatus | Genetic mutation | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Infectious diseases | Medical sciences | Aspergillus fumigatus - drug effects | Sputum - microbiology | Lung - microbiology | Aspergillosis, Allergic Bronchopulmonary - microbiology | Humans | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Antifungal Agents - therapeutic use | Bronchoalveolar Lavage Fluid - microbiology | Aspergillus fumigatus - isolation & purification | Culture Media | Polymerase Chain Reaction | Aspergillosis, Allergic Bronchopulmonary - epidemiology | Invasive Pulmonary Aspergillosis - epidemiology | Triazoles - therapeutic use | Antifungal Agents - pharmacology | Invasive Pulmonary Aspergillosis - drug therapy | Pulmonary Aspergillosis - drug therapy | DNA, Fungal - analysis | Drug Resistance, Fungal - genetics | Aspergillus fumigatus - genetics | Pulmonary Aspergillosis - microbiology | Triazoles - pharmacology | Pulmonary Aspergillosis - epidemiology | Invasive Pulmonary Aspergillosis - microbiology | Mutation | Chronic Disease | Drug resistance in microorganisms | Usage | Physiological aspects | Causes of | Lung diseases, Fungal | Research | Drug therapy | Health aspects | Fungi | Medical diagnosis | Deoxyribonucleic acid--DNA | Nonnative species | Polymorphism | Index Medicus | and Commentaries
Journal Article
Respiratory medicine, ISSN 0954-6111, 08/2018, Volume 141, pp. 121 - 131
Aspergillus | Chronic pulmonary aspergillosis | Invasive aspergillosis | Pulmonary aspergillosis | Allergic bronchopulmonary aspergillosis | Cardiac & Cardiovascular Systems | Respiratory System | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Invasive Pulmonary Aspergillosis - drug therapy | Recurrence | Triazoles - administration & dosage | Pulmonary Aspergillosis - drug therapy | Prognosis | Pyridines - administration & dosage | Humans | Environmental Exposure - prevention & control | Pulmonary Aspergillosis - diagnosis | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Pulmonary Aspergillosis - microbiology | Invasive Pulmonary Aspergillosis - diagnosis | Antifungal Agents - therapeutic use | Environmental Exposure - adverse effects | Fungi | Nitriles - administration & dosage | Pulmonary Aspergillosis - epidemiology | Aspergillus - isolation & purification | Aspergillosis, Allergic Bronchopulmonary - diagnosis | Nitriles - therapeutic use | Pyridines - therapeutic use | Triazoles - therapeutic use | Sleep disorders | Medical colleges | Triazoles | Communicable diseases | Cystic fibrosis | Respiratory agents | Drug approval | Risk factors | Therapy | Regulatory agencies | Medical imaging | Microbiology | Mycology | Medical treatment | Molds | Infections | Medical diagnosis | Patients | Asthma | Infectious diseases | Classification | Aspergillosis | Chronic obstructive pulmonary disease | Diagnosis | Clinical microbiology | Immune system | Index Medicus
Journal Article
Clinical microbiology and infection, ISSN 1198-743X, 12/2011, Volume 17, Issue 12, pp. 1882 - 1889
invasive aspergillosis | voriconazole | galactomannan | Epidemiology | outcome | Galactomannan | Invasive aspergillosis | Outcome | Voriconazole | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Human mycoses | Infectious diseases | Pharmacology. Drug treatments | Antifungal agents | Mycoses | Biological and medical sciences | Medical sciences | Miscellaneous mycoses | Antibiotics. Antiinfectious agents. Antiparasitic agents | Aspergillus - classification | Prospective Studies | Humans | Middle Aged | Male | Antifungal Agents - therapeutic use | Incidence | Young Adult | Aged, 80 and over | Aspergillus - isolation & purification | Adult | Female | Seasons | Invasive Pulmonary Aspergillosis - epidemiology | Invasive Pulmonary Aspergillosis - drug therapy | France - epidemiology | Risk Factors | Invasive Pulmonary Aspergillosis - mortality | Drug Therapy, Combination - methods | Hospitals | Invasive Pulmonary Aspergillosis - microbiology | Mannans - blood | Adolescent | Aged | Immunocompromised Host | Analysis | Leukemia | Aspergillosis | Stem cells | Transplantation of organs, tissues, etc | Respiratory tract diseases | Transplantation | Risk factors | Trends | Transplants & implants | Mortality | Cell culture | Risk groups | Lung | stem cell transplantation | Central nervous system | Immunoproliferative diseases | Lipids | Regression analysis | Inflammatory diseases | Seasonal variations | Caspofungin | Geriatrics | Tumors | Index Medicus | Life Sciences | Aspergillus | Microbiology and Parasitology | Invasive Pulmonary Aspergillosis | Mannans | Antifungal Agents | Drug Therapy, Combination | France
Journal Article
Journal Article